The role of water and protein flexibility in the structure-based virtual screening of allosteric GPCR modulators: an mGlu5 receptor case study

被引:9
|
作者
Orgovan, Zoltan [1 ]
Ferenczy, Gyorgy G. [1 ]
Keseru, Gyorgy M. [1 ]
机构
[1] Hungarian Acad Sci, Res Ctr Nat Sci, Med Chem Res Grp, Magyar Tudosok Krt 2, H-1117 Budapest, Hungary
关键词
Metabotropic glutamate receptor 5; Virtual screening; Induced fit binding; Structural water; METABOTROPIC GLUTAMATE RECEPTORS; DRUG DISCOVERY; COUPLED RECEPTORS; BINDING POCKETS; LIGAND; INSIGHTS; DOCKING; ANTAGONISTS; PARAMETERS; DATABASE;
D O I
10.1007/s10822-019-00224-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stabilizing unique receptor conformations, allosteric modulators of G-protein coupled receptors (GPCRs) might open novel treatment options due to their new pharmacological action, their enhanced specificity and selectivity in both binding and signaling. Ligand binding occurs at intrahelical allosteric sites and involves significant induced fit effects that include conformational changes in the local protein environment and water networks. Based on the analysis of available crystal structures of metabotropic glutamate receptor 5 (mGlu(5)) we investigated these effects in the binding of mGlu(5) receptor negative allosteric modulators. A large set of retrospective virtual screens revealed that the use of multiple protein structures and the inclusion of selected water molecules improves virtual screening performance compared to conventional docking strategies. The role of water molecules and protein flexibility in ligand binding can be taken into account efficiently by the proposed docking protocol that provided reasonable enrichment of true positives. This protocol is expected to be useful also for identifying intrahelical allosteric modulators for other GPCR targets.
引用
收藏
页码:787 / 797
页数:11
相关论文
共 50 条
  • [21] Does considering water molecules and protein flexibility matter in structure based virtual screening?
    Weill, Nathanael
    Therrien, Eric
    Moitessier, Nicolas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [22] Identification of novel farnesoid X receptor modulators using a combined ligand- and structure-based virtual screening
    Achenbach, Janosch
    Gabler, Matthias
    Steri, Ramona
    Schubert-Zsilavecz, Manfred
    Proschak, Ewgenij
    MEDCHEMCOMM, 2013, 4 (06) : 920 - 924
  • [23] Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors
    Hou, Xuben
    Rooklin, David
    Yang, Duxiao
    Liang, Xiao
    Li, Kangshuai
    Lu, Jianing
    Wang, Cheng
    Xiao, Peng
    Zhang, Yingkai
    Sun, Jin-peng
    Fang, Hao
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2018, 58 (11) : 2331 - 2342
  • [24] Identification of potentialLeishmania chagasisuperoxide dismutase allosteric modulators by structure-based computational approaches: homology modelling, molecular dynamics and pharmacophore-based virtual screening
    de Souza, Bruno Cruz
    Lacerda, Pedro Sousa
    da Rocha Pita, Samuel Silva
    Kato, Rodrigo Bentes
    Andrade Leite, Franco Henrique
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (18): : 7000 - 7016
  • [25] Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile)
    Christopher, John A.
    Aves, Sarah J.
    Bennett, Kirstie A.
    Dore, Andrew S.
    Errey, James C.
    Jazayeri, Ali
    Marshall, Fiona H.
    Okrasa, Krzysztof
    Serrano-Vega, Maria J.
    Tehan, Benjamin G.
    Wiggin, Giselle R.
    Congreve, Miles
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (16) : 6653 - 6664
  • [26] Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening
    Park, Hwangseo
    Chien, Pham Ngoc
    Ryu, Seong Eon
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (20) : 6333 - 6337
  • [27] Structure-based drug discovery using GPCR homology modeling: Successful virtual screening for antagonists of the Alpha1A adrenergic receptor
    Evers, A
    Klabunde, T
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) : 1088 - 1097
  • [28] Identifying TRPV1 modulators by structure-based virtual screening: A case study of using drug discovery tools at mcule.com
    Szalai, Ferenc
    Kovacs, Laszlo
    Olah, Zoltan
    Kiss, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [29] Identification of Novel Protein Kinase Receptor Type 2 Inhibitors Using Pharmacophore and Structure-Based Virtual Screening
    Cruz, Josiane V.
    Neto, Moyses F. A.
    Silva, Luciane B.
    Ramos, Ryan da S.
    Costa, Josivan da S.
    Brasil, Davi S. B.
    Lobato, Cleison C.
    da Costa, Glauber V.
    Bittencourt, Jose Adolfo H. M.
    da Silva, Carlos H. T. P.
    Leite, Franco H. A.
    Santos, Cleydson B. R.
    MOLECULES, 2018, 23 (02):
  • [30] Discovery of 2-(2-Benzoxazoyl amino)-4-Aryl-5-Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound
    Mueller, Ralf
    Dawson, Eric S.
    Meiler, Jens
    Rodriguez, Alice L.
    Chauder, Brian A.
    Bates, Brittney S.
    Felts, Andrew S.
    Lamb, Jeffrey P.
    Menon, Usha N.
    Jadhav, Sataywan B.
    Kane, Alexander S.
    Jones, Carrie K.
    Gregory, Karen J.
    Niswender, Colleen M.
    Conn, P. Jeffrey
    Olsen, Christopher M.
    Winder, Danny G.
    Emmitte, Kyle A.
    Lindsley, Craig W.
    CHEMMEDCHEM, 2012, 7 (03) : 406 - 414